Epithelial Nf-Kappa B Activation Promotes Urethane-Induced Lung Carcinogenesis

Georgios T. Stathopoulos,Taylor P. Sherrill,Dong-Sheng Cheng,Robert M. Scoggins,Wei Han,Vasiliy V. Polosukhin,Linda Connelly,Fiona E. Yull,Barbara Fingleton,Timothy S. Blackwell
DOI: https://doi.org/10.1073/pnas.0705316104
2007-01-01
Abstract:Chronic inflammation is linked to carcinogenesis in several organ systems. In the lungs, NF-kappa B, a central effector of inflammatory responses, is frequently activated in non-small-cell lung cancer, but its role in tumor promotion has not been studied. Several lines of evidence indicate that ethyl carbamate (urethane)-induced lung tumor formation, a prototypical mouse model of multistage lung carcinogenesis, is potentiated by inflammation. We found that mouse strains susceptible to lung tumor formation (FVB, BALB/c) exhibited early NF-kappa B activation and inflammation in the lungs after urethane treatment. However, a resistant strain (C57B6) failed to activate NF-kappa B or induce lung inflammation. In FVB mice, we identified urethane-induced NF-kappa B activation in airway epithelium, as well as type II alveolar epithelial cells and macrophages. Using an inducible transgenic mouse model (FVB strain) to express a dominant inhibitor of NF-kappa B specifically in airway epithelial cells, we found that urethane-induced lung inflammation was blocked and tumor formation was reduced by > 50%. Selective NF-kappa B inhibition resulted in increased apoptosis of airway epithelial cells at 2 weeks after urethane treatment in association with a marked reduction of Bcl-2 expression. These studies indicate that NF-kappa B signaling in airway epithelium is integral to tumorigenesis in the urethane model and identify the NF-kappa B pathway as a potential target for chemoprevention of lung cancer.
What problem does this paper attempt to address?